Diabetes research and clinical practice · 2025
IDF diabetes Atlas: A worldwide review of studies utilizing retinal photography to screen for diabetic retinopathy from 2017 to 2024 inclusive.
СтатьяОбзорМетаанализНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Owens David R, Gurudas Sarega, Sivaprasad Sobha, Zaidi Farhan, Tapp Robyn, Kazantzis Dimitrios, Evans Lizzy, Thomas Rebecca L
Аннотация
AIMS: This study aimed to report the global prevalence of diabetic retinopathy (DR) based on retinal imaging, using English-language articles published from 2017 to June 2024.
METHODS: Three databases-Cochrane Library, Embase via OVID, and Medline via OVID-were searched using subject headings and keywords. An independent librarian conducted the initial search and developed the strategy. A total of 569 publications were uploaded to Rayyan for blinded screening, yielding 42 studies. Meta-analysis was performed to determine prevalence rates for any DR, proliferative DR (PDR), diabetic macular oedema (DMO), and sight-threatening DR (STDR).
RESULTS: Global prevalence rates across the 7 IDF regions were: any DR 23 % (95 % CI: 20-26), PDR 6 % (95 % CI: 3-9), DMO 5 % (95 % CI: 4-6), and STDR 11 % (95 % CI: 9-14). Compared to 2015-2019 data, the rate of any DR decreased from 27 % to 23 %, while PDR increased from 1.4 % to 6 %. DMO rates remained stable (∼5%).
CONCLUSION: Global DR prevalence remains between 20 and 30%. However, variations in study design and regional practices limit trend interpretation. International screening guidelines, supported by advancing technology, are needed to produce robust epidemiological data for global Eye Health policy planning.
METHODS: Three databases-Cochrane Library, Embase via OVID, and Medline via OVID-were searched using subject headings and keywords. An independent librarian conducted the initial search and developed the strategy. A total of 569 publications were uploaded to Rayyan for blinded screening, yielding 42 studies. Meta-analysis was performed to determine prevalence rates for any DR, proliferative DR (PDR), diabetic macular oedema (DMO), and sight-threatening DR (STDR).
RESULTS: Global prevalence rates across the 7 IDF regions were: any DR 23 % (95 % CI: 20-26), PDR 6 % (95 % CI: 3-9), DMO 5 % (95 % CI: 4-6), and STDR 11 % (95 % CI: 9-14). Compared to 2015-2019 data, the rate of any DR decreased from 27 % to 23 %, while PDR increased from 1.4 % to 6 %. DMO rates remained stable (∼5%).
CONCLUSION: Global DR prevalence remains between 20 and 30%. However, variations in study design and regional practices limit trend interpretation. International screening guidelines, supported by advancing technology, are needed to produce robust epidemiological data for global Eye Health policy planning.